Making space for anti-infective drug discovery
1Department of Microbiology and Immunology, Weill Cornell Medical College, New York, NY 10065, USA. cnathan@med.cornell.edu
Cell Host & Microbe
|May 18, 2011
Summary
The search for new anti-infective treatments is declining due to limited exploration of research areas. Wider investigation across diverse scientific spaces is crucial for novel drug discovery.
Area of Science:
- Microbiology
- Drug Discovery
- Medicinal Chemistry
Background:
- The pipeline for novel anti-infective agents is critically low, posing a significant threat to public health.
- Current drug discovery efforts face challenges due to over-reliance on restricted research domains.
Purpose of the Study:
- To highlight the limitations in current anti-infective research strategies.
- To advocate for broader exploration across multiple scientific dimensions.
Main Methods:
- Analysis of trends in anti-infective drug discovery.
- Review of target space, screening space, and chemical space limitations.
Main Results:
- Discovery efforts are concentrated in narrow regions, limiting novel findings.
- Existing research paradigms fail to adequately explore the full potential of anti-infective development.
Conclusions:
- Expanding exploration across diverse target, screening, and chemical spaces is essential.
- A paradigm shift in research strategy is necessary to revitalize the discovery of effective anti-infective treatments.
Related Concept Videos
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
Antibiotic Selection
Overview


